Mumbai, India | April 20th, 2026: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved a significant global regulatory milestone with the successful Good Manufacturing Practice (GMP) approvals from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). This